ALLMedicine™ Acinetobacter Center

Sep 25th, 2021 - A global upsurge in antibiotic resistant Acinetobacter baumannii requires supervised selection of biocides and disinfectants to avert nosocomial infections by reducing its spread. On the other hand, inadequate and improper biocides have been repor...

Sep 22nd, 2021 - Infection is the second leading cause of death in patients with cancer. Loss of efficacy in antibiotics due to antibiotic resistance in bacteria is an urgent threat against the continuing success of cancer therapy. In this review, the authors focu...

Sep 20th, 2021 - The KL26 gene cluster responsible for the synthesis of the K26 capsular polysaccharide (CPS) of Acinetobacter baumannii includes rmlBDAC genes for l-rhamnose (l-Rhap) synthesis, tle to generate 6-deoxy-l-talose (l-6dTalp) from l-Rhap, and a manC g...

Sep 17th, 2021 - To investigate the clinical features and outcomes of patients with mechanical ventilation-associated pneumonia (VAP) caused by Acinetobacter baumannii (Ab), and to characterize the drug resistance of pathogenic strains and carbapenem resistance-as...

Sep 15th, 2021 - Acinetobacter baumannii is a nosocomial pathogen that has emerged as a major threat in the health-care settings, particularly intensive care units (ICUs). The aim of this study was to investigate the prevalence of A. baumannii in the environment o...

Nov 27th, 2019 - The polymyxins are important agents for carbapenem-resistant Gram-negative bacilli. The United States Committee on Antimicrobial Susceptibility Testing breakpoint recommendations for colistin and polymyxin B are that isolates of Pseudomonas aerugi...

Oct 7th, 2015 - Acinetobacter baumannii constitutes a dreadful problem in many ICUs worldwide. The very limited therapeutic options available for these organisms are a matter of great concern. No specific guidelines exist addressing the prevention and management ...

Sep 28th, 2010 - The Association for Professionals in Infection Control and Epidemiology (APIC) began publishing their series of Elimination Guides in 2007. Since then, 9 Elimination Guides have been developed that cover a range of important infection prevention i...

Nov 23rd, 2020 - Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. On July 1, 2020, when I began a rotation on the infectious disease consult service at the Veterans Administration Hospital in Atlanta, we had three patients with...

Summary Company Announcement Date: May 28, 2019 FDA Publish Date: May 28, 2019 Product Type: Drugs Reason for Announcement: Recall Reason Description Sterility Failure Company Name: Heritage Pharmaceuticals Inc. Brand Name: Brand Name(s) Heritage ...

Nov 14th, 2018 - ORLANDO – More therapies are becoming available for children for the treatment of influenza and multidrug-resistant infections such as Enterobacteriaceae and Acinetobacter, John S. Bradley, MD, said at the annual meeting of the American Academy of.

Oct 8th, 2018 - SAN FRANCISCO — Five standout antibiotics were featured during a pipeline session here at IDWeek 2018. The application process was open to all companies and the agents selected had the most novel data and are likely to have to most impact, said Ce...

Jul 11th, 2018 - Results Data were categorized into 16 different bacterial genera or species. Acinetobacter (n = 1), Kluyvera ascorbata (n = 2), and Stenotrophomonas maltophilia (n = 3) were underrepresented in the dataset and therefore were not included in the da.